ABBV vs IDA · P/E 81, rev $61.16B vs P/E 24, rev $1.77B
AbbVie Inc (ABBV) versus IDACORP Inc (IDA) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
IDACORP Inc (IDA) is a utilities - regulated electric company listed on NYSE.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported IDA revenue for 2024-12-31 was $1.77B. Net income was $290.0M. Revenue was up 7.9% from 2023-12-31 to 2024-12-31. IDA currently screens at market cap $7.87B and trailing P/E 23.6.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. IDA currently screens at market cap $7.87B and trailing P/E 23.6.
Not investment advice. Open the ABBV and IDA stock pages for the full models.
Not investment advice.